BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

635 related articles for article (PubMed ID: 20008656)

  • 1. Genotype-phenotype correlations in Charcot-Marie-Tooth disease type 2 caused by mitofusin 2 mutations.
    Calvo J; Funalot B; Ouvrier RA; Lazaro L; Toutain A; De Mas P; Bouche P; Gilbert-Dussardier B; Arne-Bes MC; Carrière JP; Journel H; Minot-Myhie MC; Guillou C; Ghorab K; Magy L; Sturtz F; Vallat JM; Magdelaine C
    Arch Neurol; 2009 Dec; 66(12):1511-6. PubMed ID: 20008656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early onset severe and late-onset mild Charcot-Marie-Tooth disease with mitofusin 2 (MFN2) mutations.
    Chung KW; Kim SB; Park KD; Choi KG; Lee JH; Eun HW; Suh JS; Hwang JH; Kim WK; Seo BC; Kim SH; Son IH; Kim SM; Sunwoo IN; Choi BO
    Brain; 2006 Aug; 129(Pt 8):2103-18. PubMed ID: 16835246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MFN2 mutation distribution and genotype/phenotype correlation in Charcot-Marie-Tooth type 2.
    Verhoeven K; Claeys KG; Züchner S; Schröder JM; Weis J; Ceuterick C; Jordanova A; Nelis E; De Vriendt E; Van Hul M; Seeman P; Mazanec R; Saifi GM; Szigeti K; Mancias P; Butler IJ; Kochanski A; Ryniewicz B; De Bleecker J; Van den Bergh P; Verellen C; Van Coster R; Goemans N; Auer-Grumbach M; Robberecht W; Milic Rasic V; Nevo Y; Tournev I; Guergueltcheva V; Roelens F; Vieregge P; Vinci P; Moreno MT; Christen HJ; Shy ME; Lupski JR; Vance JM; De Jonghe P; Timmerman V
    Brain; 2006 Aug; 129(Pt 8):2093-102. PubMed ID: 16714318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic epidemiology of Charcot-Marie-Tooth disease.
    Braathen GJ
    Acta Neurol Scand Suppl; 2012; (193):iv-22. PubMed ID: 23106488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Axonal neuropathy with optic atrophy is caused by mutations in mitofusin 2.
    Züchner S; De Jonghe P; Jordanova A; Claeys KG; Guergueltcheva V; Cherninkova S; Hamilton SR; Van Stavern G; Krajewski KM; Stajich J; Tournev I; Verhoeven K; Langerhorst CT; de Visser M; Baas F; Bird T; Timmerman V; Shy M; Vance JM
    Ann Neurol; 2006 Feb; 59(2):276-81. PubMed ID: 16437557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Molecular genetics of inherited neuropathies].
    Takashima H
    Rinsho Shinkeigaku; 2006 Jan; 46(1):1-18. PubMed ID: 16541790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and electrophysiologic features of CMT2A with mutations in the mitofusin 2 gene.
    Lawson VH; Graham BV; Flanigan KM
    Neurology; 2005 Jul; 65(2):197-204. PubMed ID: 16043786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterizing the phenotypic manifestations of MFN2 R104W mutation in Charcot-Marie-Tooth type 2.
    Genari AB; Borghetti VH; Gouvêa SP; Bueno KC; dos Santos PL; dos Santos AC; Barreira AA; Lourenço CM; Marques W
    Neuromuscul Disord; 2011 Jun; 21(6):428-32. PubMed ID: 21531138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic spectrum of MFN2 mutations in the Spanish population.
    Casasnovas C; Banchs I; Cassereau J; Gueguen N; Chevrollier A; Martínez-Matos JA; Bonneau D; Volpini V
    J Med Genet; 2010 Apr; 47(4):249-56. PubMed ID: 19889647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cohort study of MFN2 mutations and phenotypic spectrums in Charcot-Marie-Tooth disease 2A patients.
    Choi BO; Nakhro K; Park HJ; Hyun YS; Lee JH; Kanwal S; Jung SC; Chung KW
    Clin Genet; 2015 Jun; 87(6):594-8. PubMed ID: 24863639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotype/phenotype correlations in X-linked dominant Charcot-Marie-Tooth disease.
    Hahn AF; Bolton CF; White CM; Brown WF; Tuuha SE; Tan CC; Ainsworth PJ
    Ann N Y Acad Sci; 1999 Sep; 883():366-82. PubMed ID: 10586261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cohort study of Han Chinese MFN2-related Charcot-Marie-Tooth 2A.
    Lv H; Wang L; Zhang W; Wang Z; Zuo Y; Liu J; Yuan Y
    J Neurol Sci; 2015 Nov; 358(1-2):153-7. PubMed ID: 26382835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A French family with Charcot-Marie-Tooth disease related to simultaneous heterozygous MFN2 and GDAP1 mutations.
    Vital A; Latour P; Sole G; Ferrer X; Rouanet M; Tison F; Vital C; Goizet C
    Neuromuscul Disord; 2012 Aug; 22(8):735-41. PubMed ID: 22546700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autosomal recessive axonal Charcot-Marie-Tooth disease (ARCMT2): phenotype-genotype correlations in 13 Moroccan families.
    Bouhouche A; Birouk N; Azzedine H; Benomar A; Durosier G; Ente D; Muriel MP; Ruberg M; Slassi I; Yahyaoui M; Dubourg O; Ouazzani R; LeGuern E
    Brain; 2007 Apr; 130(Pt 4):1062-75. PubMed ID: 17347251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and electrophysiological features in Charcot-Marie-Tooth disease with mutations in the NEFL gene.
    Miltenberger-Miltenyi G; Janecke AR; Wanschitz JV; Timmerman V; Windpassinger C; Auer-Grumbach M; Löscher WN
    Arch Neurol; 2007 Jul; 64(7):966-70. PubMed ID: 17620486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mutations in the mitofusin 2 gene are the most common cause of Charcot-Marie-Tooth type 2 disease].
    Sołtysińska E; Kabzińska D; Kochański A
    Neurol Neurochir Pol; 2007; 41(4):350-4. PubMed ID: 17874344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of disease and clinical features of mutations of the gene for mitofusin 2: an important cause of hereditary peripheral neuropathy with striking clinical variability in children and adults.
    Ouvrier R; Grew S
    Dev Med Child Neurol; 2010 Apr; 52(4):328-30. PubMed ID: 20163430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ultrastructural lesions of axonal mitochondria in patients with childhood-onset Charcot-Marie-Tooth disease due to MFN2 mutations].
    Funalot B; Magdelaine C; Sturtz F; Ouvrier R; Vallat JM
    Bull Acad Natl Med; 2009 Jan; 193(1):151-60; discussion 160-1. PubMed ID: 19718987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Charcot-Marie-Tooth neuropathy type 2A: novel mutations in the mitofusin 2 gene (MFN2).
    Engelfried K; Vorgerd M; Hagedorn M; Haas G; Gilles J; Epplen JT; Meins M
    BMC Med Genet; 2006 Jun; 7():53. PubMed ID: 16762064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe early-onset axonal neuropathy with homozygous and compound heterozygous MFN2 mutations.
    Nicholson GA; Magdelaine C; Zhu D; Grew S; Ryan MM; Sturtz F; Vallat JM; Ouvrier RA
    Neurology; 2008 May; 70(19):1678-81. PubMed ID: 18458227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.